Chemung Canal Trust Company Has Lifted Bristol (BMY) Holding By $1.81 Million; Hahn Capital Management Has Raised Covanta Holdings (CVA) Position

Hahn Capital Management Llc increased Covanta Holdings (CVA) stake by 0.96% reported in 2017Q3 SEC filing. Hahn Capital Management Llc acquired 10,906 shares as Covanta Holdings (CVA)’s stock declined 11.25%. The Hahn Capital Management Llc holds 1.15M shares with $17.08B value, up from 1.14M last quarter. Covanta Holdings now has $1.92B valuation. It closed at $14.8 lastly. It is up 13.10% since March 11, 2017 and is downtrending. It has underperformed by 29.80% the S&P500.

Chemung Canal Trust Company increased Bristol (BMY) stake by 35.69% reported in 2017Q3 SEC filing. Chemung Canal Trust Company acquired 28,653 shares as Bristol (BMY)’s stock declined 1.04%. The Chemung Canal Trust Company holds 108,932 shares with $6.94M value, up from 80,279 last quarter. Bristol now has $110.89 billion valuation. The stock increased 1.75% or $1.17 during the last trading session, reaching $67.92. About 6.26M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since March 11, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Among 11 analysts covering Covanta (NYSE:CVA), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Covanta has $25 highest and $12.50 lowest target. $17.63’s average target is 19.12% above currents $14.8 stock price. Covanta had 49 analyst reports since October 8, 2015 according to SRatingsIntel. The stock of Covanta Holding Corporation (NYSE:CVA) earned “Hold” rating by Stifel Nicolaus on Monday, February 13. Stifel Nicolaus maintained the shares of CVA in report on Friday, March 18 with “Buy” rating. Stifel Nicolaus upgraded the stock to “Buy” rating in Monday, July 31 report. The firm has “Buy” rating given on Friday, September 1 by Robert W. Baird. Imperial Capital maintained Covanta Holding Corporation (NYSE:CVA) rating on Thursday, February 18. Imperial Capital has “Outperform” rating and $17 target. The firm has “Outperform” rating given on Wednesday, January 20 by Oppenheimer. The firm has “Neutral” rating by Macquarie Research given on Friday, August 26. The company was maintained on Thursday, July 6 by Stifel Nicolaus. The stock of Covanta Holding Corporation (NYSE:CVA) has “Outperform” rating given on Thursday, October 29 by Imperial Capital. Robert W. Baird downgraded the shares of CVA in report on Friday, April 29 to “Neutral” rating.

Since December 12, 2017, it had 1 buying transaction, and 1 sale for $85,985 activity. $335,172 worth of stock was sold by Lynch Thomas J. Jr. on Tuesday, December 12. Another trade for 4,000 shares valued at $249,187 was bought by Samuels Theodore R. II.

Chemung Canal Trust Company decreased The (NYSE:TRV) stake by 24,162 shares to 4,125 valued at $506,000 in 2017Q3. It also reduced Merck (NYSE:MRK) stake by 24,624 shares and now owns 103,112 shares. General (NYSE:GE) was reduced too.

Investors sentiment decreased to 0.94 in Q3 2017. Its down 0.09, from 1.03 in 2017Q2. It worsened, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. First Commercial Bank Of Omaha reported 16,364 shares stake. Partnervest Advisory Svcs Limited Com stated it has 0.39% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Botty Investors Ltd Co owns 1.38% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 67,729 shares. Caprock Gp stated it has 24,692 shares or 0.33% of all its holdings. The New York-based Roosevelt Investment Gp Incorporated has invested 0.02% in Bristol-Myers Squibb Company (NYSE:BMY). Suntrust Banks holds 570,627 shares or 0.2% of its portfolio. Jensen Invest Mgmt Inc holds 33,000 shares or 0.03% of its portfolio. Regal Investment Ltd Liability Company invested 0.06% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Cutter & Brokerage holds 30,538 shares or 0.77% of its portfolio. Biondo Inv Advsr Limited Liability Corporation has invested 2.02% in Bristol-Myers Squibb Company (NYSE:BMY). Financial Bank Of America Corporation De holds 0.12% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 11.53M shares. Saturna Corporation invested in 684,513 shares or 1.41% of the stock. Manchester Capital Mngmt Ltd Com invested in 0.08% or 7,638 shares. Davis R M invested 0.06% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Ok owns 0.61% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 156,790 shares.